The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,141,316 in first-year total cost, median $227,781.
Most frequent study sections
- Behavioral Medicine, Interventions and Outcomes Study Section[BMIO]3
- Molecular Neuropharmacology and Signaling Study Section[MNPS]2
- Clinical Neuroplasticity and Neurotransmitters Study Section[CNNT]1
- Drug Discovery for the Nervous System Study Section[DDNS]1
- Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section[NPAS]1
Most frequent institutions
- BROWN UNIVERSITY1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- JOHNS HOPKINS UNIVERSITY1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- SEATTLE CHILDREN'S HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Role of sleep deficiency in self-management of pediatric chronic pain1R21NR017312-01A1 | PALERMO, TONYA M | SEATTLE CHILDREN'S HOSPITAL, WA | $238,444 | BMIO |
| 2018 | Targeting ASIC3 to disrupt nociceptor sensitization following spinal cord injury1R21NS104789-01A1 | BAUMBAUER, KYLE M | UNIVERSITY OF CONNECTICUT STORRS, CT | $233,419 | CNNT |
| 2018 | Enduring reversal of chronic pain by adenosine 2a agonism1R21NS102932-01A1 | WATKINS, LINDA | UNIVERSITY OF COLORADO, CO | $231,000 | NNRS |
| 2018 | Development of a Selective Mu-Delta Opioid Receptor Heterodimer Antagonist Using a Linked Bivalent Pharmacophore Approach1R21DA044509-01A1 | STREICHER, JOHN MICHAEL | UNIVERSITY OF ARIZONA, AZ | $230,250 | MNPS |
| 2018 | Sumatriptan and MOH: Differential 5-HT1R signaling in trigeminal nociceptors1R21NS094488-01A1 | BERG, KELLY ANNCLARKE, WILLIAM P | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $228,750 | MNPS |
| 2018 | Single cell transcriptional analysis of spinal cord in a neuropathic pain model1R21NS106337-01 | ZYLKA, MARK J. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $226,811 | ZRG1 |
| 2018 | Developing brain stimulation as a treatment for pain in opiate dependent individuals1R21DA044503-01A1 | HANLON, COLLEEN A | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $224,250 | NPAS |
| 2018 | Therapeutic potential of enhanced mitochondrial biogenesis for paclitaxel-induced peripheral neuropathy1R21CA226672-01 | HIRANO, MICHIO | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $208,800 | NOMD |
| 2018 | Development and Preliminary Testing of Novel Virtual Human-Assisted Psychosocial Interviews for Patients with Chronic Musculoskeletal Pain1R21AR074020-01 | JUNGHAENEL, DOERTE ULRIKELUMLEY, MARK A | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $207,280 | BMIO |
| 2017 | Identifying Pain Trajectories In Sickle Cell Disease Using Latent Class Analysis1R21MD011455-01 | RODDAY, ANGIE MAE | TUFTS MEDICAL CENTER, MA | $262,500 | NRCS |
| 2017 | Orosensory pain following oxaliplatin chemotherapy1R21DE027237-01 | ROPER, STEPHEN D. | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $230,250 | SCS |
| 2017 | Physician-Patient Communication, Decision Making and Management in Chronic Pain.1R21DA042265-01A1 | LAWS, MICHAEL BARTON | BROWN UNIVERSITY, RI | $216,385 | BMIO |
| 2017 | Positive allosteric modulators of MrgX1 for the treatment of chronic pain1R21NS101954-01 | TSUKAMOTO, TAKASHI | JOHNS HOPKINS UNIVERSITY, MD | $204,115 | DDNS |
| 2017 | Identification of novel analgesic targets in ascending spinal projection neurons1R21NS100469-01A1 | BACCEI, MARK L | UNIVERSITY OF CINCINNATI, OH | $199,062 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.